During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
Ahead of the Curve®
Dec 13, 2023
A New Chapter In Biosecurity: Are We Prepared?
Read More >
Ahead of the Curve®
Sep 19, 2023
Investors Guide to Immuno-Oncology
Read More >
Ahead of the Curve®
Aug 1, 2023
MRD 2.0: Deep Dive Into The Coming Solid Tumor Opportunity
Read More >
Ahead of the Curve®
Jun 9, 2023
5th Annual Investor Primer on Antibody Drug Conjugates
Read More >
Ahead of the Curve®
Apr 25, 2023
A Primer On The Next Generation Of Radiopharmaceuticals
Read More >
Ahead of the Curve®
Mar 13, 2023
The Biotech Executive: Bold, Tenacious, And Accountable
Read More >
Ahead of the Curve®
Jan 27, 2023
The Price Is (Not) Right: Discounts, 340B, Access, And IRA
Read More >
Ahead of the Curve®
Dec 28, 2022
Single Cell & Spatialomics: What Does The Future Hold?
Read More >
Ahead of the Curve®
Nov 3, 2022
Profoundly Expanding the Target Space: A Primer on TPD
Read More >
Ahead of the Curve®
Oct 3, 2022
The PRMT5 Edge: Every Uncertainty Presents an Opportunity
Read More >
Video
Ahead of the Curve®
Sep 27, 2022
Trials & Triumphs of the FDA: What Matters? Where are We?
Read More >
Ahead of the Curve®
Sep 20, 2022
Liquid Biopsy Deep Dive: MRD in Solid Tumors
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.